Chapters
Chapter 1
Introduction
How neutrophils kill fungi
Immunological Reviews 2016 (273) Sept; in press
Chapter 2
Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency’’
Blood 2013; 121(13):2385-92.
Chapter 3
Chronic Candida albicans meningitis in a 4-year-old girl with a homozygous mutation in the CARD9 gene (Q295X)
Pediatr Infect Dis J 2015; 34(9):999-1002.
Chapter 4
Extrapulmonary Aspergillus infection in patients with CARD9 Deficiency.
J Allergy Clin Immunol 2016; resubmitted
Chapter 5
Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2/Munc18-2 mutations.
Blood 2013; 122(1):109-11.
Chapter 6
Impaired microbial killing by neutrophils from patients with PKC delta deficiency.
J Allergy Clin Immunol 2015; 136(5):1404-7.
http://www.ncbi.nlm.nih.gov/pubmed/26233929
Chapter 7
Neutrophil specific granule deficiency and impaired NETosis in Gray Platelet Syndrome.
J Clin Invest 2016; submitted
Chapter 8
Pro-inflammatory response to fungal but not to bacterial pathogens in Chronic Granulomatous Disease.
J Allergy Clin Immunol 2016 May; in press
Chapter 9
Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects.
Blood 2014; 124(4):590-7.
Chapter 10
Human neutrophils employ distinct mechanisms for the killing of Aspergillus fumigatus conidia and hyphae: evidence from phagocyte defects.
J Immunol 2016; 196(3):1272-83.
Chapter 11
G-CSF/dexamethasone mobilized granulocytes for transfusion purposes are impaired in Candida albicans killing.
Haematologica 2016; 101(5):587-96.
Chapter 12
Characterization of buffy-coat-derived granulocytes for clinical use: a comparison with GCSF/dexamethasone-treated donor-derived products.
Vox Sang 2016; submitted
Chapter 13
Discussion
